Search details
1.
Hematological, clinical, immunophenotypic characterization, and treatment outcomes of prognostically significant genetic subtypes of B-lineage acute lymphoblastic leukemia: A report of 1021 patients from India.
Cancer
; 129(21): 3390-3404, 2023 Nov 01.
Article
in English
| MEDLINE | ID: mdl-37498973
2.
Advanced glycation end-products (AGEs) are lower in prostate tumor tissue and inversely related to proportion of West African ancestry.
Prostate
; 82(3): 306-313, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34855273
3.
Association between inflammatory bowel disease and prostate cancer: A large-scale, prospective, population-based study.
Int J Cancer
; 147(10): 2735-2742, 2020 11 15.
Article
in English
| MEDLINE | ID: mdl-32399975
4.
RAMP1 is a direct NKX3.1 target gene up-regulated in prostate cancer that promotes tumorigenesis.
Am J Pathol
; 183(3): 951-63, 2013 Sep.
Article
in English
| MEDLINE | ID: mdl-23867798
5.
Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC.
Nat Commun
; 15(1): 352, 2024 Jan 08.
Article
in English
| MEDLINE | ID: mdl-38191557
6.
Tumorigenic polyploid cells contain elevated ROS and ARE selectively targeted by antioxidant treatment.
J Cell Physiol
; 227(2): 801-12, 2012 Feb.
Article
in English
| MEDLINE | ID: mdl-21503880
7.
Haploinsufficiency at the Nkx3.1 locus. A paradigm for stochastic, dosage-sensitive gene regulation during tumor initiation.
Cancer Cell
; 3(3): 273-83, 2003 Mar.
Article
in English
| MEDLINE | ID: mdl-12676585
8.
Interactions between cells with distinct mutations in c-MYC and Pten in prostate cancer.
PLoS Genet
; 5(7): e1000542, 2009 Jul.
Article
in English
| MEDLINE | ID: mdl-19578399
9.
A MYC inhibitor selectively alters the MYC and MAX cistromes and modulates the epigenomic landscape to regulate target gene expression.
Sci Adv
; 8(17): eabh3635, 2022 04 29.
Article
in English
| MEDLINE | ID: mdl-35476451
10.
A Genome-Wide CRISPR Activation Screen Identifies PRRX2 as a Regulator of Enzalutamide Resistance in Prostate Cancer.
Cancer Res
; 82(11): 2110-2123, 2022 06 06.
Article
in English
| MEDLINE | ID: mdl-35405009
11.
Inflammatory bowel disease induces inflammatory and pre-neoplastic changes in the prostate.
Prostate Cancer Prostatic Dis
; 25(3): 463-471, 2022 09.
Article
in English
| MEDLINE | ID: mdl-34035460
12.
Turning Up the Heat on MYC: Progress in Small-Molecule Inhibitors.
Cancer Res
; 81(2): 248-253, 2021 01 15.
Article
in English
| MEDLINE | ID: mdl-33087323
13.
FIREWORKS: a bottom-up approach to integrative coessentiality network analysis.
Life Sci Alliance
; 4(2)2021 02.
Article
in English
| MEDLINE | ID: mdl-33328249
14.
Early-onset metastatic and clinically advanced prostate cancer is a distinct clinical and molecular entity characterized by increased TMPRSS2-ERG fusions.
Prostate Cancer Prostatic Dis
; 24(2): 558-566, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33420417
15.
Macrophages expedite cell proliferation of prostate intraepithelial neoplasia through their downstream target ERK.
FEBS J
; 288(6): 1871-1886, 2021 03.
Article
in English
| MEDLINE | ID: mdl-32865335
16.
Activated ALK Cooperates with N-Myc via Wnt/ß-Catenin Signaling to Induce Neuroendocrine Prostate Cancer.
Cancer Res
; 81(8): 2157-2170, 2021 04 15.
Article
in English
| MEDLINE | ID: mdl-33637566
17.
Posttranslational regulation of FOXA1 by Polycomb and BUB3/USP7 deubiquitin complex in prostate cancer.
Sci Adv
; 7(15)2021 04.
Article
in English
| MEDLINE | ID: mdl-33827814
18.
Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.
BMC Cancer
; 10: 248, 2010 Jun 01.
Article
in English
| MEDLINE | ID: mdl-20515470
19.
Genomic Profiling of Prostate Cancers from Men with African and European Ancestry.
Clin Cancer Res
; 26(17): 4651-4660, 2020 09 01.
Article
in English
| MEDLINE | ID: mdl-32651179
20.
Organoids Increase the Predictive Value of in vitro Cancer Chemoprevention Studies for in vivo Outcome.
Front Oncol
; 9: 77, 2019.
Article
in English
| MEDLINE | ID: mdl-30842936